MD

MEDNAX

NYSE

Real-time Quotes | Nasdaq Last Sale

31.69

+0.01

+0.03%

Opening 12:15 06/22 EDT

OPEN

31.70

PREV CLOSE

31.68

HIGH

32.00

LOW

31.16

VOLUME

64.97K

TURNOVER

52 WEEK HIGH

34.19

52 WEEK LOW

12.47

MARKET CAP

2.73B

P/E (TTM)

185.00

Tenet Healthcare (THC) to Divest Hospitals for $1.1 Billion

Zacks.com · 4d ago

Tenet Healthcare (THC) Soars 69% YTD: More Room to Run?

Zacks.com · 6d ago

Community Health (CYH) Soars 111% YTD: More Room to Run?

Zacks.com · 06/09 16:39

Correction: Mizuho Securities Maintains Price Target for Mednax at $30, Reiterates Neutral Rating

MT Newswires · 06/07 16:20

--Mizuho Securities Adjusts Mednax PT to $20 From $30, Maintains Neutral Rating

MT Newswires · 06/07 12:35

Mednax Stock Shows Every Sign Of Being Modestly Overvalued

GuruFocus News · 06/06 08:01

Insider Trends: MEDNAX Insider Continues Selling Trend with Tax Sale

MT Newswires · 06/02 16:24

Frazier Healthcare Partners Closes Oversubscribed $1.4 Billion Growth Buyout Fund

, /PRNewswire/ -- , a leading healthcare-focused investment firm, has closed its 10th dedicated healthcare private equity fund focused on the middle market. Frazier Healthcare Growth Buyout Fund X, L.P. (FHGB X) was oversubscribed and hit its hard cap of ...

PR Newswire - PRF · 05/27 13:01

Forecast

Actual (USD)

Estimate (USD)

Income StatementMore

Net Income (USD)

YoY (%)

Balance SheetMore

Total Assets (USD)

Total Liabilities (USD)

Debt to Asset (%)

Cash FlowMore

Operating (USD)

YoY (%)

Learn about the latest financial forecast of MD. Analyze the recent business situations of MEDNAX through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.

Analyst Rating

Based on 10 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average MD stock price target is 27.00 with a high estimate of 35.00 and a low estimate of 14.00.

EPS

Institutional Holdings

Institutions: 383

Institutional Holdings: 102.02M

% Owned: 118.36%

Shares Outstanding: 86.19M

TypeInstitutionsShares

Increased

8.76M

New

2.15M

Decreased

6.74M

Sold Out

4.89M

Performance
Asset Allocation
Dividend History

No Data

Industry

Healthcare Facilities & Services

+0.19%

Healthcare Providers & Services

+0.07%

Key Executives

Non-Executive Chairman/Independent Director

Guy Sansone

Chief Executive Officer/Director

Mark Ordan

Chief Financial Officer/Executive Vice President

C. Marc Richards

Corporate Executive

Roger Hinson

Executive Vice President/General Counsel/Secretary

Dominic Andreano

Executive Vice President

Nikos Nikolopoulos

Senior Vice President/Chief Accounting Officer

John Pepia

Vice President

Kevin Smith

Lead Director/Independent Director

Manuel Kadre

Director

Roger Medel

Independent Director

Karey Barker

Independent Director

Waldemar Carlo

Independent Director

Paul Gabos

Independent Director

Thomas McEachin

Independent Director

Michael Rucker

Independent Director

John Starcher

Independent Director

Shirley Weis

No Data

All
Financials
Insiders

About MD

MEDNAX, Inc is a provider of physician services, including newborn, maternal-fetal, pediatric cardiology and other pediatric subspecialty care. The Company's national network consist of physicians, including over physicians providing neonatal clinical care, primarily within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications. It also has affiliated physicians providing maternal-fetal and obstetrical medical care to expectant mothers experiencing complicated pregnancies primarily in areas where its affiliated neonatal physicians practice. Its network also included other pediatric subspecialists, physicians providing pediatric intensive care, pediatric cardiology care, hospital-based pediatric care, pediatric surgical care, pediatric ear, nose and throat and pediatric ophthalmology services.

Webull offers kinds of MEDNAX Inc stock information, including NYSE:MD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MD stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading MD stock methods without spending real money on the virtual paper trading platform.